|
USA-OR-WARSAW Azienda Directories
|
Azienda News:
- Ionis Pharmaceuticals, Inc.
Ionis is unlocking the rapidly expanding potential of RNA- and DNA-targeted medicines to enable better futures for people living with serious diseases Building on Our Impossible Firsts, We Can Change the Course of Human Health
- Press Releases - Ionis Pharmaceuticals, Inc.
Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentum
- Ionis Pharmaceuticals - Wikipedia
Ionis Pharmaceuticals, Inc is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics
- Ionis Pharmaceuticals, Inc. (IONS) - Yahoo Finance
Find the latest Ionis Pharmaceuticals, Inc (IONS) stock quote, history, news and other vital information to help you with your stock trading and investing
- Ionis Pharmaceuticals Inc
See the latest Ionis Pharmaceuticals Inc stock price (IONS:XNAS), related news, valuation, dividends and more to help you make your investing decisions
- What Ionis Pharmaceuticals Investors Need to Know
Ionis Pharmaceuticals, Inc , a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States The company is based in Carlsbad and has 1,069 full time employees Its market capitalization is $5,850,684,928 26 analysts are following Ionis Pharmaceuticals and have set target prices ranging from $37 0 to $83 0 per
- IONS Stock Price | Ionis Pharmaceuticals Inc. Stock Quote . . . - MarketWatch
Ionis Pharmaceuticals, Inc engages in the development and commercialization of human therapeutic drugs using antisense technology The company was founded by Stanley T Crooke, David
- Ionis enters new chapter in 2025 as commercial-stage biotech with . . .
CARLSBAD, Calif , Jan 13, 2025 PRNewswire -- Ionis Pharmaceuticals, Inc (Nasdaq: IONS) today announced highlights from the Company's 2024 achievements and previewed important milestones expected in 2025
- The Ionis Story - Pioneering Innovation in Therapeutics
As a pioneer in RNA therapeutics, we have achieved firsts that were once thought impossible, including turning a rare, progressive and deadly childhood genetic disease into a chronic condition and developing the first medicine for a genetic cause of amyotrophic lateral sclerosis (ALS)
- Ionis Pharmaceuticals (IONS) Stock Price Overview
Get a real-time Ionis Pharmaceuticals, Inc (IONS) stock price with an overview of financials, statistics, forecasts, charts and more
|
|